is contracted via the University of Liverpool (no personal payment) to undertake consultancy for Altimmune, AstraZeneca, Boehringer Ingelheim, Cytoki, Eli Lilly, Napp, Novo Nordisk, Menarini, Pfizer, Rhythm Pharmaceuticals, Sanofi, Saniona, Tern Pharmaceuticals, Shionogi and Ysopia
When evaluating providers, focus on five factors
While research on tirzepatide and cancer is ongoing, there is not yet enough evidence to fully understand its long-term effects on breast cancer progression
Whilst some patients report psoriasis improvement during GLP-1 therapy, this is not guaranteed and likely relates primarily to weight loss
Whilst generally well-tolerated, allergic reactions to GLP-1 agonists can occur, ranging from mild injection site responses to rare but serious anaphylaxis